Showing results (301-310 of 355) with videos related to
Sort By:
Pageof 36
Neuropharmacology|September 6, 2002
Increased anxiety-related behavior in mice deficient for metabotropic glutamate 8 (mGlu8) receptorA-M Linden, B G Johnson, S C Peters, et al.European Journal of Nuclear Medicine and Molecular Imaging|November 23, 2025
Novel 4D radiomics applied to dynamic FES PET images to improve prediction of breast cancer response to ER-targeted therapyAndrew William Chen, Carla R Zeballos Torrez, Lanell M Peterson, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2003
Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapyDavid A Mankoff, Lisa K Dunnwald, Julie R Gralow, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2011
Between-patient and within-patient (site-to-site) variability in estrogen receptor binding, measured in vivo by 18F-fluoroestradiol PETBrenda F Kurland, Lanell M Peterson, Jean H Lee, et al.Cell Death and Differentiation|July 13, 2000
Selective localization of Bcl-2 to the inner mitochondrial and smooth endoplasmic reticulum membranes in mammalian cellsT Gotow, M Shibata, S Kanamori, et al.Cancer|January 8, 2005
Residual tumor uptake of [99mTc]-sestamibi after neoadjuvant chemotherapy for locally advanced breast carcinoma predicts survivalLisa K Dunnwald, Julie R Gralow, Georgiana K Ellis, et al.Clinical Breast Cancer|November 28, 2017
Phase I/II Trial of Combined Pegylated Liposomal Doxorubicin and Cyclophosphamide in Metastatic Breast CancerAmy E Chang, Qian V Wu, Isaac C Jenkins, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2016
Estrogen Receptor Binding (18F-FES PET) and Glycolytic Activity (18F-FDG PET) Predict Progression-Free Survival on Endocrine Therapy in Patients with ER+ Breast CancerBrenda F Kurland, Lanell M Peterson, Jean H Lee, et al.Breast Cancer Research : BCR|February 18, 2025
Fluoroestradiol (FES) and Fluorodeoxyglucose (FDG) PET imaging in patients with ER+, HER2-positive or HER2-negative metastatic breast cancerNatasha B Hunter, Lanell M Peterson, Jennifer M Specht, et al.Chemical Science|June 17, 2026
Lipids and lipid nanoparticles functionalized with randomized poly(ethylene glycol) (rPEG) for mRNA deliveryPhilip Dreier, Caroline Bockhard, David Seibel, et al.Pageof 36